Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Görk, A Semih ^a   Ehrenkranz, R A ^b   Bracken, M B ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

ATTRIBUTABLE RISK; BRAIN BLOOD FLOW; CEREBRAL PALSY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; HUMAN; KIDNEY BLOOD FLOW; MESENTERY BLOOD FLOW; META ANALYSIS; MORTALITY; NEWBORN MORTALITY; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PERCEPTION DEAFNESS; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; THROMBOCYTE DYSFUNCTION; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

EID: 44949170777     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006071.pub2     Document Type: Review

References (29)

1. Christmann 2002 {published data only} *Christmann V, Liem KD, Semmekrot BA, van de Bor M. Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin. Acta Paediatrica 2002;91:440-6.
2. Hammerman 1995 {published data only} Hammerman C, Glaser J, Schimmel MS, Ferber B, Kaplan M, Eidelman AI. Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity. Pediatrics 1995;95:244-8.
3. Austin 1992 Austin NC, Pairaudeau PW, Hames TK, Hall MA. Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants. Archives of Disease in Childhood 1992;67:851-4.
4. Brook 1995 Brook M, Heymann M. Patent ductus arteriosus. Heart Disease in Infants, Children and Adolescents including the Fetus and Young Adult. Williams and Wilkins, 1995.
5. Clyman 1996 Clyman RI. Recommendation for the postnatal use of indomethacin: an analysis of four separate treatment strategies. Journal of Pediatrics 1996;128:601-7.
6. Colditz 1989 Colditz P, Murphy D, Rolfe P, Wilkinson AR. Effect of infusion rate of indomethacin on cerebrovascular responses in preterm neonates. Archives of Disease in Childhood 1989;64:8-12.
7. Cotton 1978 Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. Journal of Pediatrics 1978;93:647-51.
8. de Vries 2005 de Vries KS, Jagroep FK, Jaarsma AS, Elzenga NJ, Bos AF. Continuous indomethacin infusion may be less effective than bolus infusion for ductal closure in very low birth weigth infants. American Journal of Perinatology 2005;22:71-5.
9. Edwards 1990 Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delpy DT, Reynolds EO. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990;335:1491-5.
10. Evans 1987 Evans DH, Levene MI, Archer LN. The effect of indomethacin on cerebral blood-flow velocity in premature infants. Developmental Medicine and Child Neurology 1987;29:776-82.
11. Fowlie 2002 Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database of Systematic Reviews 2002, Issue 3.Art. No.: CD000174. DOI:10.1002/14651858.CD000174.
12. Friedman 1976 Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. New England Journal of Mediciine 1976;295:526-9.
13. Gersony 1983 Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. Journal of Pediatrics 1983;102:895-906.
14. Herrera 2001 Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews 2001, Issue 4.Art. No.: CD003480. DOI:10.1002/14651858.CD003480.pub3.
15. Lago 2002 Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, Saia OS. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. European Journal of Pediatrics 2002;161:202-7.
16. Laudignon 1988 Laudignon N, Chemtob S, Bard H, Aranda JV. Effect of indomethacin on cerebral blood flow velocity of premature newborns. Biology of the Neonate 1988;54:254-62.
17. Mardoum 1991 Mardoum R, Bejar R, Merritt AT, Berry C. Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants. Journal of Pediatrics 1991;118:112-5.
18. Ment 1988 Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Taylor KJ, Scott DT, Gettner P, Sherwonit E, Williams J. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. Journal of Pediatrics 1988;112:948-55.
19. Ment 1993 Ment LR, Oh W, Ehrenkranz RA, Philip AG, Schneider K, Katz KH, Taylor KJ, Duncan CC, Makuch RW. Risk period for intraventricular hemorrhage of the pretermneonate is independent of gestational age. Seminars in Perinatology 1993;17:338-41.
20. Nehgme 1992 Nehgme RA, O'Connor TZ, Lister G, Bracken MB. Patent ductus arteriosus. In: SinclairJC, BrackenMB editor(s). Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992:281-324.
21. Pezzati 1999 Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1999;135:733-8.
22. Shaffer 2002 Shaffer CL, Gal P, Ransom JL, Carlos RQ, Smith MS, Davey AM, Dimaguila MA, Brown YL, Schall SA. Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus. Critical Care Medicine 2002;30:343-8.
23. Shah 2003 Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/lor low birth weight infants. Cochrane Database of Systematic Reviews 2003, Issue 2.
24. Siassi 1976 Siassi B, Blanco C, Cabal LA, Coran AG. Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: a prospective analysis of 150 consecutively born infants. Pediatrics 1976;57:347-51.
25. Simko 1994 Simko A, Mardoum R, Merritt TA, Bejar R. Effects on cerebral blood flow velocities of slow and rapid infusion of indomethacin. Journal of Perinatology 1994;14:29-35.
26. van Bel 1989 van Bel F, van de Bor M, Stijnen T, Baan J, Ruys JH. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect. Pediatrics 1989;84:802-7.
27. van Bel 1990 Van Bel F, Van Zoeren D, Schipper J, Guit GL, Baan J. Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants. Journal of Pediatrics 1990;116:965-70.
28. van Bel 1991 van Bel F, Guit GL, Schipper J, van de Bor M, Baan J. Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. Journal of Pediatrics 1991;118:621-6.
29. van Overmeire 1997 van Overmeire B, Follens I, Hartman S, Creten WL, van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Archives of Disease in Childhood Neonatal Edition 1997;76:F179-84.